<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="19798" end="19809" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="veweser" text="Due to the high molecular weight of PARP, SDS-PAGE was performed using 7% polyacrylamide gels, and proteins were then &lt;b&gt;transferred&lt;/b&gt; to PVDF membrane (Biorad) via wet transfer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="21046" end="21057" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" annotator="tofox" text="One hundred thousand cells were separated by 5% SDS-PAGE, &lt;b&gt;transferred&lt;/b&gt; by wet-transfer to PVDF membrane, and blotted as described above using monoclonal antibody specific for the N-terminus of BRCA1 (Oncogene Boston, MA)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="19798" end="19809" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="jeneale" text="Due to the high molecular weight of PARP, SDS-PAGE was performed using 7% polyacrylamide gels, and proteins were then &lt;b&gt;transferred&lt;/b&gt; to PVDF membrane (Biorad) via wet transfer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="19552" end="19563" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="carichter" text="5% SDS-polyacrylamide gels, and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose membrane (Amersham Piscataway, NJ) via semi-dry transfer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="19798" end="19809" sStart="null" offset="0" sid="null" wn="2 3" wnkey="null" annotator="carichter" text="Due to the high molecular weight of PARP, SDS-PAGE was performed using 7% polyacrylamide gels, and proteins were then &lt;b&gt;transferred&lt;/b&gt; to PVDF membrane (Biorad) via wet transfer." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="15043" end="15049" sStart="null" offset="0" sid="null" wn="1" wnkey="trace%2:31:00::" annotator="veweser" text="Previous studies have shown that truncation of the highly acidic carboxy-region BRCT resulted in resistance to caspase induced apoptosis [ 17 ] . Further, this failure of apoptosis was &lt;b&gt;traced&lt;/b&gt; specifically to caspase 8 and the Fas/FasL pathway." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="15043" end="15049" sStart="null" offset="0" sid="null" wn="5" wnkey="trace%2:39:00::" annotator="jeneale" text="Previous studies have shown that truncation of the highly acidic carboxy-region BRCT resulted in resistance to caspase induced apoptosis [ 17 ] . Further, this failure of apoptosis was &lt;b&gt;traced&lt;/b&gt; specifically to caspase 8 and the Fas/FasL pathway." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-7.anc" start="15043" end="15049" sStart="null" offset="209" sid="r7.trace.v.0016" wn="1" wnkey="trace%2:31:00::" annotator="jeneale" text="Previous studies have shown that truncation of the highly acidic carboxy-region BRCT resulted in resistance to caspase induced apoptosis [ 17 ] . Further, this failure of apoptosis was traced specifically to caspase 8 and the Fas/FasL pathway." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="15043" end="15049" sStart="null" offset="0" sid="null" wn="1" wnkey="trace%2:31:00::" annotator="cgozo" text="Previous studies have shown that truncation of the highly acidic carboxy-region BRCT resulted in resistance to caspase induced apoptosis [ 17 ] . Further, this failure of apoptosis was &lt;b&gt;traced&lt;/b&gt; specifically to caspase 8 and the Fas/FasL pathway." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-7.anc" start="15043" end="15049" sStart="null" offset="209" sid="r7.trace.v.0016" wn="3" wnkey="trace%2:38:01::" annotator="cgozo" text="Previous studies have shown that truncation of the highly acidic carboxy-region BRCT resulted in resistance to caspase induced apoptosis [ 17 ] . Further, this failure of apoptosis was traced specifically to caspase 8 and the Fas/FasL pathway." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1475-2867-2-7.anc" start="15043" end="15049" sStart="null" offset="0" sid="null" wn="5" wnkey="trace%2:39:00::" annotator="brubin" text="Previous studies have shown that truncation of the highly acidic carboxy-region BRCT resulted in resistance to caspase induced apoptosis [ 17 ] . Further, this failure of apoptosis was &lt;b&gt;traced&lt;/b&gt; specifically to caspase 8 and the Fas/FasL pathway." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-7.anc" start="15043" end="15049" sStart="null" offset="209" sid="r7.trace.v.0016" wn="1" wnkey="trace%2:31:00::" annotator="brubin" text="Previous studies have shown that truncation of the highly acidic carboxy-region BRCT resulted in resistance to caspase induced apoptosis [ 17 ] . Further, this failure of apoptosis was traced specifically to caspase 8 and the Fas/FasL pathway." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-7.anc" start="1467" end="1476" sStart="null" offset="75" sid="r8.suggest.v.0613" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="The highly acidic carboxy-terminal (BRCT) region of BRCA1 has been suggested to play a role in transactivation [ 11 ] . BRCT interacts with BRCA2, Rad51, other tumor suppressing elements, as well as numerous transcription factors, such as RNA helicase A and STAT1 [ 15 16 ] . Recently, it has been discovered that truncation of this region resulted in suppression of apoptosis following pro-apoptotic stimuli [ 17 ] . Further, these studies also suggested that the BRCT region facilitates apoptotic functions within the caspase pathway." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-7.anc" start="14267" end="14277" sStart="null" offset="80" sid="r8.suggest.v.0207" wn="3" wnkey="suggest%2:32:02::" annotator="brubin" text="As with DFF45, PARP cleavage was significantly enhanced in BRCA1+ cells suggesting that decreased DNA repair capacity in BRCA1+ cells may, in part, be due to premature inactivation of PARP." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-7.anc" start="13838" end="13842" sStart="null" offset="198" sid="r7.poor.j.0689" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="veweser" text="The cleavage and subsequent deactivation of this caspase 3-dependent DNase inhibitor suggested that amino-terminal BRCA1 mutations enhance cellular apoptosis contributing to poor cell survival." />
    <s path="[OANC]/data/written_2/technical/biomed/1475-2867-2-7.anc" start="13838" end="13842" sStart="null" offset="198" sid="r7.poor.j.0689" wn="4" wnkey="poor%3:00:02::" annotator="jeneale" text="The cleavage and subsequent deactivation of this caspase 3-dependent DNase inhibitor suggested that amino-terminal BRCA1 mutations enhance cellular apoptosis contributing to poor cell survival." />
  </sentences>
</list>